Manufacturing, Cell-Line Selection

Catalent Introduces New Next-Generation Cell-Line Development Technology

November 06, 2019

The technology is set to heighten the company’s GPEx expression platform through the utilization of a glutamine synthase knock-out Chinese hamster ovary cell line.

Lonza Enters Manufacturing Agreement with Cellectis for CAR T Cell Development

October 03, 2019

Manufacturing of the cell line will take place at Lonza’s GMP facility in Geleen, Netherlands.

Sartorius Stedim Biotech Launches New Mammalian Cell Bank Services

August 08, 2019

The company has launched new services for mammalian cell bank manufacturing under GMP conditions.

FUJIFILM Invests in New Continuous Processing Facility

June 07, 2019

The $10-million investment will include a 500-L single-use perfusion bioreactor and seven patented downstream processing units.

Selexis Expands Immuno-Oncology Alliance with Agenus

January 10, 2019

Agenus will leverage Selexis’ SUREtechnology Platform to progress Agenus’ portfolio of next-generation antibody programs.

Media Requirements for Different Cell Sources

November 02, 2018

This article will explore the requirements for media and supplements needed to maintain newer cell lines, such as those based on human cells and fungal cells.

MilliporeSigma Offers Insect Platform for Viral Vaccines and Gene Therapy Development

October 15, 2018

The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.

Maintaining Cell-Line Integrity is Critical to Product Quality

September 25, 2018

Cell-line quality has a significant impact on biologic drug quality; learn more about this and other upstream challenges at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.

The Challenge of Building Better Biologic Drugs

August 02, 2018

Development costs and time to market continue to put pressure on the biopharma industry, driving the need for innovation in methods and technologies.

Catalent Implements Optofluidic Platform for Cell-Line Development

July 12, 2018

Pharmaceutical Technology's In the Lab eNewsletter

Catalent Biologics will adopt Berkeley Lights’ Beacon optofluidic platform for its cell-line development workflow.